Showing 1–5 of 5 results
-
Amendments and Corrections |
-
Research |
-
Research |
-
Research | | Open
-
Research |
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease
- V Bachanova
- , D I Marks
- , M-J Zhang
- , H Wang
- , M de Lima
- , M D Aljurf
- , M Arellano
- , A S Artz
- , U Bacher
- , J-Y Cahn
- , Y-B Chen
- , E A Copelan
- , W R Drobyski
- , R P Gale
- , J P Greer
- , V Gupta
- , G A Hale
- , P Kebriaei
- , H M Lazarus
- , I D Lewis
- , V A Lewis
- , J L Liesveld
- , M R Litzow
- , A W Loren
- , A M Miller
- , M Norkin
- , B Oran
- , J Pidala
- , J M Rowe
- , B N Savani
- , W Saber
- , R Vij
- , E K Waller
- , P H Wiernik
- & D J Weisdorf
